616 related articles for article (PubMed ID: 19264578)
1. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use.
Wu CY; Wu CH; Wu MS; Wang CB; Cheng JS; Kuo KN; Lin JT
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):427-31. PubMed ID: 19264578
[TBL] [Abstract][Full Text] [Related]
2. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
[TBL] [Abstract][Full Text] [Related]
4. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
5. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
6. Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.
Sadic J; Borgström A; Manjer J; Toth E; Lindell G
Aliment Pharmacol Ther; 2009 Aug; 30(4):392-8. PubMed ID: 19508403
[TBL] [Abstract][Full Text] [Related]
7. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study.
Lassen A; Hallas J; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 May; 101(5):945-53. PubMed ID: 16573778
[TBL] [Abstract][Full Text] [Related]
8. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
Manuel D; Cutler A; Goldstein J; Fennerty MB; Brown K
Aliment Pharmacol Ther; 2007 Jun; 25(12):1423-7. PubMed ID: 17539981
[TBL] [Abstract][Full Text] [Related]
9. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients.
Kamada T; Hata J; Kusunoki H; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
Dig Liver Dis; 2005 Jan; 37(1):39-43. PubMed ID: 15702858
[TBL] [Abstract][Full Text] [Related]
11. Early eradication has a lower risk of peptic ulcer bleeding in Helicobacter pylori-infected chronic kidney disease patients.
Hsu CH; Hu HY; Huang N; Chang SS
Eur J Intern Med; 2016 Sep; 33():112-7. PubMed ID: 27449117
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of peptic ulcer in 4943 inpatients.
Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
[TBL] [Abstract][Full Text] [Related]
13. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
14. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study.
Schimke K; Chubb SA; Davis WA; Phillips P; Davis TM
Diabet Med; 2009 Jan; 26(1):70-5. PubMed ID: 19125763
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological changes in peptic ulcer and their relation with Helicobacter pylori. Hospital Daniel A Carrion 2000-2005].
Montes Teves P; Salazar Ventura S; Monge Salgado E
Rev Gastroenterol Peru; 2007; 27(4):382-8. PubMed ID: 18183280
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on Helicobacter pylori infection in peptic ulcer disease patients with or without previous eradication therapy.
Chen LW; Chien RN; Fang KM; Yen CL; Chang JJ; Lee TS; Liu CJ; Chang LC
Hepatogastroenterology; 2007 Dec; 54(80):2209-11. PubMed ID: 18265634
[TBL] [Abstract][Full Text] [Related]
18. Use of anti-secretory medication: a population-based cohort study.
Lassen A; Hallas J; Schaffalitzky De Muckadell OB
Aliment Pharmacol Ther; 2004 Sep; 20(5):577-83. PubMed ID: 15339329
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of peptic ulcer disease.
Kurata JH; Haile BM
Clin Gastroenterol; 1984 May; 13(2):289-307. PubMed ID: 6378441
[TBL] [Abstract][Full Text] [Related]
20. Peptic ulcer among rural population in a selected region of south-eastern Poland.
Schabowski J; Pitera J
Ann Agric Environ Med; 2004; 11(2):323-7. PubMed ID: 15627344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
